ACUTE PYELONEPHRITIS
Clinical trials for ACUTE PYELONEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE PYELONEPHRITIS trials appear
Sign up with your email to follow new studies for ACUTE PYELONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibiotic duo takes on tough UTIs in head-to-head trial
Disease control CompletedThis study tested a new antibiotic called cefepime-zidebactam against a standard antibiotic (meropenem) in about 530 adults hospitalized with complicated urinary tract infections or kidney infections. The goal was to see if the new drug works as well and is safe. Participants rec…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Wockhardt • Aim: Disease control
Last updated May 17, 2026 08:51 UTC
-
New antibiotic combo shows promise for tough UTIs
Disease control CompletedThis study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against a standard treatment for complicated urinary tract infections and kidney infections in adults. About 614 participants took part to see if the new drugs work better or as well …
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 08:45 UTC
-
New drug cocktail takes on superbugs in major trial
Disease control CompletedThis study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against the best current treatments for serious infections like urinary tract, kidney, lung, and abdominal infections caused by carbapenem-resistant bacteria. 126 adults participated.…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Could a pill replace the IV for serious UTIs? new study investigates
Disease control CompletedThis study tested an oral antibiotic (tebipenem pivoxil hydrobromide) against a standard IV antibiotic in 1690 hospitalized adults with complicated urinary tract infections or acute kidney infections. The goal was to see if the oral drug works as well as the IV treatment in curin…
Matched conditions: ACUTE PYELONEPHRITIS
Phase: PHASE3 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated May 06, 2026 16:02 UTC